Skip to main content
. 2023 Nov 28;14:1238757. doi: 10.3389/fimmu.2023.1238757

Table 2.

The heterogeneity and sensitivity results of RA and thyroid function after removal of pleiotropic IVs.

Exposure-outcome nSNP MR Egger intercept Cochran’s heterogeneity test
Intercept value P IVW-Q value P (IVW) Egger-Q value P (Egger)
Hypothyroidism-RA 34 -0.0469 0.207 1058.7397 4.11E-201 1006.5788 7.05E-191
GD-RA 4 0.1376 0.018 53.7322 1.28E-11 1.0231 0.600
other types of hyperthyroidism-RA 6 0.1532 0.661 1057.9187 1.73E-226 1001.8007 1.45E-215
TSH-RA 39 -0.0080 0.267 50.5121 0.084 48.8353 0.092
FT4-RA 18 -0.0125 0.434 35.9153 0.005 34.5283 0.005
RA-Hypothyroidism 69 -0.0148 0.127 505.025 5.40E-68 469.202 1.09E-61
RA-GD 73 0.0276 0.067 365.270 8.23E-41 348.305 3.41E-38
RA-other types of hyperthyroidism 78 0.0234 0.081 303.373 1.27E-28 285.143 5.91E-26
RA-TSH 69 -0.0034 0.143 86.6897 0.063 83.9360 0.079
RA-FT4 70 0.0021 0.367 78.982 0.193 78.034 0.190

MR, Mendelian randomization; IVW, inverse variance-weighted; nSNP, number of single nucleotide polymorphisms; IVW, inverse variance weighted; RA, rheumatoid arthritis; GD, Graves’ disease; FT4, free thyroxine; TSH, thyroid-stimulating hormone.